The regeneration of oligodendrocytes is a crucial step in recovery from demyelination, as surviving oligodendrocytes exhibit limited structural plasticity and rarely form additional myelin sheaths.
| I N TR ODU C TI ON
In the central nervous system (CNS), oligodendrocytes serve two principal functions; they generate myelin sheaths that enable fast and efficient impulse conduction and, in a more recently appreciated role, they provide both metabolic and trophic support to axons (Funfschilling et al., 2012; Nave, 2010) . Destruction or loss of myelin results in impaired saltatory conduction and perturbed neural circuitry in the short-term, but if sustained can lead to neurodegeneration. The functional consequences of CNS demyelination are apparent in patients suffering from multiple sclerosis (MS), an immune-mediated disease that destroys myelin, oligodendrocytes and ultimately axons (Ferguson, Matyszak, Esiri, & Perry, 1997; Tallantyre et al., 2010) .
In a reparative process known as remyelination, platelet-derived growth factor receptor a (PDGFRa) expressing oligodendrocyte progenitor cells (OPCs) can proliferate, migrate to demyelinated lesion sites and subsequently differentiate into myelinating oligodendrocytes.
Remyelination restores axonal function and health and thus limits neurodegeneration in the long-term (Duncan, Brower, Kondo, Curlee Jr, & Schultz, 2009; Franklin & Ffrench-Constant, 2008; Schultz et al., 2017) .
Unfortunately, this process is often inefficient or can fail completely for reasons that are not well understood. Genetic fate-mapping studies in mouse models of MS have greatly added to our knowledge of the cellular dynamics of OPC-mediated remyelination (Furusho, Roulois, Franklin, & Bansal, 2015; Tripathi, Rivers, Young, Jamen, & Richardson, 2010; Xing et al., 2014; Zawadzka et al., 2010) . While these studies indicate that OPCs are primarily responsible for mediating CNS remyelination, there has been some controversy regarding their ultimate commitment to the oligodendrocyte fate and whether OPCs resident in the parenchyma or those derived from the subventricular zone are Glia. 2017; 65:2087 -2098 wileyonlinelibrary.com/journal/glia V C 2017 Wiley Periodicals, Inc. | 2087 primarily responsible for repair (Brousse, Magalon, Durbec, & Cayre, 2015; Franco, Silvestroff, Soto, & Pasquini, 2008; Franklin & Gallo, 2014; Guglielmetti et al., 2014; Xing et al., 2014) . The cellular composition, extent of inflammation, and extracellular matrix are distinct in gray versus white matter following demyelination (Bo, Vedeler, Nyland, Trapp, & Mork, 2003; Brink et al., 2005; Chang et al., 2012; Peterson, Bo, Mork, Chang, & Trapp, 2001 ), but we do not yet understand if the dynamics of de-and remyelination are affected by these differing environments. Thus, further studies using these models are paramount to understanding the cues, both cell intrinsic and environmental, that determine the potential of OPCs to differentiate and remyelinate.
MS was long considered a disease of the white matter, but recent magnetic resonance imaging (MRI) and pathology studies have revealed extensive gray matter demyelination in MS patients, which is thought to make a significant contribution to disease burden (Klaver et al., 2015; Rudick & Trapp, 2009 ). Indeed, gray matter atrophy has been found to correlate more strongly with cognitive and physical disability than white matter atrophy (Fisniku et al., 2008) . Notably, observations from cortical lesions spanning both white and gray matter indicate that these differing environments may influence the timing, and potentially the efficiency, of remyelination (Albert, Antel, Bruck, & Stadelmann, 2007; Chang et al., 2012 for a total of 6 weeks to induce demyelination. Mice were returned to a regular diet after this time to allow remyelination ( Figure 1b ).
| 4-Hydroxytamoxifen administration
4-hydroxytamoxifen (4-HT, Sigma-Aldrich) was prepared as previously described (Badea, Wang, & Nathans, 2003) . Two weeks after the start of cuprizone feeding, PDGFRa-Cre ER ;Rosa26-eYFP mice were injected with a total of 3 mg of 4-HT over three days to induce recombination ( Figure 1 ). Recombination was induced in control mice (no cuprizone exposure) at 10 weeks of age.
| Immunohistochemistry and Black Gold II staining
Control or cuprizone-treated mice were euthanized at 4, 6, 7, 8, 10, and 12 weeks following initiation of the experiment (Figure 1b 
| Image acquisition and analysis
Black Gold II stained sections were imaged on a BX41 Olympus microscope using ImageProPlus5.1 software (Media Cybernetics). For lineage tracing, slides were imaged using a Zeiss Axio Observer Z1 epifluorescence microscope and Axiovision software with the appropriate excitation and emission filters. A total of four sections were examined per mouse, and eight mice (4 male, 4 female) were analyzed per group.
Areas were chosen randomly within the regions of interest. Postacquisition image analysis and cell counts were performed using Zeiss Zen software.
| Statistical analysis
Statistical analyses were conducted using the GraphPad Prism software (GraphPad 
Rosa26-eYFP mice is not affected by cuprizone administration
To follow the fate of OPCs after cuprizone-induced demyelination, we crossed hemizygous PDGFRa-Cre ER transgenic mice (Kang et al., 2010) with the Rosa26-eYFP reporter strain ( Figure 1a ). Equal numbers of male and female double transgenic mice were then assigned to either a control or cuprizone diet. As previous studies indicated that OPCs first begin to accumulate in the corpus callosum 2 weeks after initiating the cuprizone challenge, and peak between 2 to three weeks thereafter (Gudi et al., 2009; Xing et al., 2014) , we administered 4-HT at 2 weeks 
| Rapid repopulation of the demyelinated corpus callosum by OPC-derived oligodendrocytes
We selected the body of the corpus callosum (above the fornix) to study the dynamics of white matter de-and re-myelination, as this provides fiducial landmarks for comparisons between animals. Black Gold II staining revealed that extensive demyelination was apparent by 4 weeks, with the lowest levels of myelin by 6 weeks of cuprizone treatment (Figure 2a, c) . Remyelination followed, such that by 6 weeks of recovery, the intensity of area stained with Black Gold II was not significantly different from control mice. A significant decrease in the number of CC1-immunoreactive (CC11) oligodendrocytes was also found after 4 weeks of cuprizone treatment (Figure 2a,d ), but this rapidly rebounded by 6 weeks of cuprizone (despite continued treatment), and persisted over the 6 subsequent recovery weeks. Interestingly, the density of CC11 oligodendrocytes at 6 weeks of recovery was greater than that of control mice treated for 10 weeks, suggesting that cuprizone-induced injury leads to differentiation of more oligodendrocytes than would be expected without injury. In support of this, the density of PDGFRa1
OPCs at 4 weeks of cuprizone-treatment was 2.53 greater than agematched controls (Figure 2a ,e) and their density remained elevated until week seven, indicating that there is a massive mobilization of progenitors after demyelination to differentiate and remyelinate the corpus callosum.
To determine whether new oligodendrocytes were derived from OPCs born after cuprizone exposure, fate-mapping analysis was performed on transgenic mice that were induced to express eYFP in a subset of OPCs during the second week of cuprizone exposure (PDGFRa-Cre ER ;Rosa26-eYFP), and then were analyzed 2 weeks later for eYFP expression in mature oligodendrocytes. The number of PDGFRa1/eYFP1 OPCs was significantly greater post-cuprizone than control-treated animals at this time point. However, unlike the PDGFRa1 OPC counts (Figure 2e ), the number of PDGFRa1/eYFP1 cells ( Figure 2b ) did not remain significantly elevated relative to controltreated mice past this initial time-point. Rather, there was a steady and significant rise in the number of CC11/eYFP1 oligodendrocytes from 6 weeks of cuprizone treatment and across 6 weeks of recovery, indicating that the majority of the OPCs labeled at 2 weeks of cuprizone treatment differentiated into mature oligodendrocytes. This demonstrates that cuprizone-treatment mobilizes a pool of OPCs in the corpus callosum that proliferate and then differentiate into mature oligodendrocytes, at a rate greater than control-fed, age-matched animals.
| Gray matter remyelination is mediated through slow repopulation by parenchymal OPCs
In contrast to the relatively rapid rate in the corpus callosum, the reap- To assess whether this delay in OPC mobilization is specific to this region of the cortex or is a general feature of gray matter demyelination, we examined the dynamics of demyelination and remyelination in the stratum lacunosum moleculare (SLM) region of the hippocampus, a region that contains myelinated fibers from the temporoammonic pathway. The behavior of OPCs, as assessed by counting PDGFRa1
OPCs and PDGFRa1/eYFP1 OPCs in PDGFRa-CreER;Rosa26-eYFP mice, revealed a similarly delayed response as in the cingulate cortex.
Black Gold II staining intensity was lowest after 6 weeks of cuprizonetreatment (Figure 4a,c) . Unlike recovery in the cingulate cortex, by 6 weeks black gold II staining was comparable to control mice. Moreover, the density of CC11 oligodendrocytes in the hippocampus was also lowest after 6 weeks of cuprizone treatment, and slowly increased to the level of control mice over 6 weeks of recovery. (Figure 4a Figure 6 ).
| OPCs remain committed to the oligodendrocyte lineage following cuprizone-induced demyelination
OPCs (PDGFRa1, NG21) have been shown to exhibit lineage plasticity in vitro depending on the combination of growth factors in the extracellular media (Kondo & Raff, 2000) and in vivo in response to traumatic injury (Vigano et al., 2016) 
| D I SCUSSION
OPCs are widely distributed throughout gray and white matter and constitute between 5-8% of the total cell population in the adult CNS (Dawson, Polito, Levine, & Reynolds, 2003; Gallo, Mangin, Kukley, & Dietrich, 2008) . These cells retain the ability to proliferate and differentiate long after the early postnatal period of intense myelination has ended, and continue to add new oligodendrocytes to brain circuits, albeit at slower rates, establishing these cells as the most abundant progenitors in the adult brain. Although long suspected to be the source of new oligodendrocytes following demyelination (Di Bello, Dawson, Levine, & Reynolds, 1999; Levine, Stincone, & Lee, 1993; Reynolds et al., 2002) , this hypothesis was confirmed when in vivo genetic labeling of OPCs revealed that they are mobilized after demyelination and differentiate into myelinating oligodendrocytes (Rivers et al., 2008; Tripathi, Rivers, Young, Jamen, & Richardson, 2010; Xing et al., 2014; Zawadzka et al., 2010) . The development and fate of OPCs in both health and disease contexts has been studied extensively in white matter, but much less is known about the dynamics of these progenitors in gray matter regions. In this study, we used double trans- Timeline at the top summarizes experimental protocol, with cuprizone supplementation over 6 weeks, followed up to 6 weeks of recovery (with animals euthanized at 4, 6, 7, 8, 10, and 12 weeks). 4-HT was administered at 2 weeks of cuprizone (arrowhead). (a) The dynamics of myelin loss and replacement in a white matter region (corpus callosum, blue lines) and two gray matter regions (cingulate cortex, red lines; hippocampus, green lines). The mean value of Black Gold II signal per time-point and region was normalized to the 4-week no cuprizone control time point (4-week no cuprizone control (not shown) set at 100%; n58 per time-point, with standard error of the mean). The black arrow marks the nadir of myelin signal intensity (6 weeks) for both white and gray matter regions. The loss of myelin is at peak for white matter by 4 weeks but not until 6 weeks for gray matter structures. After removing cuprizone, the corpus callosum is first to recover, and remyelination in the gray matter regions is slower. (b) The dynamics of YFP1 oligodendrocytes in white and gray matter over the course of demyelination and remyelination. The mean density of YFP1 CC11 mature oligodendrocytes per 1,000,000 lm 2 is depicted (n55-8 per time point, with standard error of the mean). Similar to remyelination dynamics in (a), YFP1 oligodendrocytes repopulate the corpus callosum between 4 and 6 weeks of cuprizone treatment and prior to increase in gray matter regions. Of note, there may be a second wave of new YFP1 oligodendrocytes in the corpus callosum after 10 weeks. New oligodendrocytes appear in the hippocampus and cingulate cortex in smaller numbers, a slower rate, and at least 2 weeks later than in the corpus callosum cuprizone treatment, the number of PDGFRa1/eYFP1 cells rose significantly above that observed in control mice, coincident with a significant drop in the density of CC11 oligodendrocytes. At later timepoints, the relative number of PDGFRa1/eYFP1 cells appear to decrease, corresponding to the same time course of remyelination and increase in the CC11/eYFP1 population increases (depicted in Figure   6 , blue lines) over 6 weeks of recovery. In contrast to this relatively rapid repair process within the corpus callosum, the response in both gray matter regions (cingulate cortex and the hippocampus) was slower ( Figure 6 , red and green lines, respectively). Here, loss of CC11 oligodendrocytes and maximal demyelination occurred by 6 weeks, in accordance with previous findings (Norkute et al., 2009; Skripuletz et al., 2008 Skripuletz et al., , 2011 . The production of CC11/eYFP1 cells (and myelin) in gray matter regions was delayed and remained significantly below Beyond proximity to the SVZ, there may be environmental factors inherent to the white or gray matter that influence the rate of OPC accumulation and/or differentiation. For example, while cuprizoneinduced demyelination of the corpus callosum is accompanied by a rapid and robust microgliosis, the response microglia in the cortex to cuprizone is less pronounced (Buschmann et al., 2012; Gudi et al., 2009 ). Since activated microglia and macrophages can play a key role in OPC recruitment (Kotter, Zhao, van Rooijen, & Franklin, 2005) , this muted microglial response could be another potential explanation for delayed OPC mobilization in the cortex. Gray matter regions such as the cortex have also been noted to exhibit reduced astrogliosis in response to cuprizone, when compared with the corpus callosum (Buschmann et al., 2012; Hibbits, Yoshino, Le, & Armstrong, 2012) .
While the role of astrocytes in remyelination is still poorly understood, there is evidence that reactive astrocytes may regulate myelin clearance and subsequent remyelination by promoting microglial recruitment (Skripuletz et al., 2013) .
Since deviation from the oligodendrocyte lineage has been reported (Guo, Ma, McCauley, Bannerman, & Pleasure, 2009; Tripathi et al., 2010; Zhu, Bergles, & Nishiyama, 2008) using in vivo fate tracing approaches similar to those used here, we investigated whether eYFP1 cells might co-immunolabel with either GFAP or NeuN 6 weeks after cuprizone exposure. In agreement with previous work published using this PDGFRa-Cre ER transgenic mouse line, we did not see any eYFP1
cells that were co-immunolabeled with GFAP, indicating that even under conditions of demyelination and reactive astrogliosis, OPCs do not deviate to an astrocytic fate. We observed rare eYFP1 neurons in these animals, an observation consistent with the small number of neurons that exhibit direct recombination in this line (Kang et al., 2010) . Thus, in the context of demyelination, OPCs either remain in the progenitor state or differentiate into oligodendrocytes to restore myelin sheaths.
One limitation of our ex vivo approach is that we cannot definitively exclude whether there is regionally distinct recombination efficiency or cuprizone-induced YFP1 cell death over the time course of cuprizone-induced loss and recovery. Ideally, imaging methods will be developed to longitudinally image the fate of individual cells in both white and gray matter regions simultaneously over the course of demyelination and recovery following cuprizone.
Both white and gray mater demyelination significantly contribute to disease burden in MS. It is therefore of vital importance to understand the factors that may hinder or aide successful remyelination in these regions. Using genetic fate tracing, this study reveals a significant difference in the dynamic response of OPCs to cuprizone-induced demyelination in the corpus callosum when compared with the cingulate cortex and hippocampus. Identifying environmental cues that aide OPC recruitment and/differentiation in gray matter will help to generate strategies to successfully promote remyelination in brain circuits and prevent cognitive decline.
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